RE:Liver biopsy imperfect diagnostic standard We know that the 50k cost per patient for unreliable liver biopsy method is the reason everything failed in the pas couple of years. They were hoping for new less invasive methods to be accepted by FDA/EMA but they did'nt get a break with that. Madrigal found a way around it anyhow, maybe luck, maybe something else. But it worked.